When Tiba Biotech was included in the cancelation of $500 million worth grants funding mRNA vaccine development, the company ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...